1. Home
  2. POR vs CRSP Comparison

POR vs CRSP Comparison

Compare POR & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POR
  • CRSP
  • Stock Information
  • Founded
  • POR 1889
  • CRSP 2013
  • Country
  • POR United States
  • CRSP Switzerland
  • Employees
  • POR N/A
  • CRSP N/A
  • Industry
  • POR Electric Utilities: Central
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • POR Utilities
  • CRSP Health Care
  • Exchange
  • POR Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • POR 4.7B
  • CRSP 5.6B
  • IPO Year
  • POR N/A
  • CRSP 2016
  • Fundamental
  • Price
  • POR $47.68
  • CRSP $54.59
  • Analyst Decision
  • POR Hold
  • CRSP Buy
  • Analyst Count
  • POR 12
  • CRSP 18
  • Target Price
  • POR $46.91
  • CRSP $73.47
  • AVG Volume (30 Days)
  • POR 1.3M
  • CRSP 2.4M
  • Earning Date
  • POR 10-31-2025
  • CRSP 11-04-2025
  • Dividend Yield
  • POR 4.39%
  • CRSP N/A
  • EPS Growth
  • POR N/A
  • CRSP N/A
  • EPS
  • POR 2.78
  • CRSP N/A
  • Revenue
  • POR $3,511,000,000.00
  • CRSP $38,050,000.00
  • Revenue This Year
  • POR $5.06
  • CRSP N/A
  • Revenue Next Year
  • POR $4.84
  • CRSP $391.94
  • P/E Ratio
  • POR $17.24
  • CRSP N/A
  • Revenue Growth
  • POR 5.09
  • CRSP N/A
  • 52 Week Low
  • POR $39.55
  • CRSP $30.04
  • 52 Week High
  • POR $48.40
  • CRSP $78.48
  • Technical
  • Relative Strength Index (RSI)
  • POR 75.37
  • CRSP 34.23
  • Support Level
  • POR $44.55
  • CRSP $64.80
  • Resistance Level
  • POR $46.62
  • CRSP $58.75
  • Average True Range (ATR)
  • POR 0.80
  • CRSP 3.45
  • MACD
  • POR 0.16
  • CRSP -1.63
  • Stochastic Oscillator
  • POR 85.99
  • CRSP 9.59

About POR Portland General Electric Co

Portland General Electric is a regulated electric utility providing generation, transmission, and distribution services in a service territory that includes about half of all Oregon residents and two-thirds of the state's business activity. The company owns (wholly or through joint ventures) 3.5 gigawatts of gas, coal, wind, and hydro generation along with 100 megawatts of energy storage.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: